Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • TREATMENT OUTCOMES AND CLINICAL RELEVANCE IN PATIENTS WITH DOUBLE EXPRESSOR DLBCL Sirapat Rungwittayatiwat1, Paisarn Boonsakan2, Pichika Chantrathammachart1, Teeraya Puavilai1, Sulada Pukiat1, Sithakom Phusanti1,3, Kochawan Boonyawat1, Pathawut Wacharapornin1, Pantep Angchaisuksiri1, Artit Ungkanont1,3, Suporn Chuncharunee1 Pimjai Niparuck1

    PIMJAI NIPARUCK
    e2021063
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.063
    1213
    PDF: 565
    HTML: 226
  • Orbital Infiltration in a Patient with Waldenström Macroglobulinemia: Need for Multidisciplinary Approach and Comparison with the Literature

    Riccardo Paggi, Francesca Mariotti, Jessica Mencarini, Silvia Bresci, Irene Capolmi, Filippo Bartalesi, Beatrice Borchi, Luca Nassi, Alessandro Maria Vannucchi, Alessandro Bartoloni
    e2023028
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.028
    1039
    PDF: 804
    HTML: 378
  • The correlation between ineffective erythropoiesis biomarkers and development of extramedullary hematopoiesis in patients with thalassemia

    Siriyakorn Chansai, Supawadee Yamsri, Supan Fucharoen, Goonnapa Fucharoen, Nattiya Teawtrakul
    e2022052
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.052
    1186
    PDF: 497
    HTML: 249
  • JC Virus leuko-encephalopathy in reduced intensity conditioning cord blood transplant recipient.

    jean elcheikh
    e2012043
    2012-06-20
    https://doi.org/10.4084/mjhid.2012.043
    1141
    PDF: 852
    HTML: 10944
  • THERAPY-RELATED MYELOID NEOPLASMS IN PATIENTS TREATED FOR HODGKIN LYMPHOMA

    Dennis A Eichenauer, Andreas Engert
    e2011046
    2011-10-24
    https://doi.org/10.4084/mjhid.2011.046
    2333
    PDF: 782
    HTML: 1228
  • ANORECTAL PATHOLOGIES IN THE COURSE OF ACUTE LEUKAEMIAS: PREDICTIVE PARAMETERS Anorectal pathologies in leukemias

    Fatma Yılmaz, Bugra Saglam, Ufuk Gorduk, Ugur Kalan, Hacer Berna Afacan Öztürk, Ahmet Kursad Gunes, Murat Albayrak
    e2024071
    2024-08-31
    https://doi.org/10.4084/MJHID.2024.071
    1222
    PDF: 755
    Html: 108
  • PREVALENCE OF ANEMIA, IRON DEFICIENCY, AND IRON DEFICIENCY ANEMIA AND DIAGNOSTIC PERFORMANCE OF HEMATOLOGIC AND BIOCHEMICAL MARKERS OF SIDEROPENIA IN 1- TO 5-YEAR-OLD CHILDREN IN THRACE GREECE Prevalence of ID, IDA and anemia in Greek Thrace

    Panagiota Zikidou, Christina Tsigalou, Gregorios Trypsianis, Alexandros Karvelas, Aggelos Tsalkidis, Elpis Mantadakis
    e2022054
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.054
    2069
    PDF: 907
    HTML: 365
  • Life-threatening autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura: successful seletive splenic artery embolization

    matteo molica, Fulvio Massaro, Giorgia Annechini, Erminia Baldacci, Gianna maria D'elia, Riccardo Rosati, Silvia maria trisolini, Paola Volpicelli, Robin Foà, Saveria Capria
    e2016020
    2016-04-10
    https://doi.org/10.4084/mjhid.2016.020
    3533
    PDF: 1017
    HTML: 2359
  • EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA

    Linjuan Xu
    e2025058
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.058
    1522
    PDF: 806
    Suppl. Files: 339
    Html: 141
  • SECOND-GENERATION TYROSINE KINASE INHIBITORS (TKI) AS SALVAGE THERAPY FOR RESISTANT OR INTOLERANT PATIENTS TO PRIOR TKIs

    Massimo Breccia, Giuliana Alimena
    e2014003
    2014-01-02
    https://doi.org/10.4084/mjhid.2014.003
    3329
    PDF: 1240
    HTML: 3490
  • Zanubrutinib as upfront treatment in de-novo B-cell prolymphocytic leukemia: the case of two elderlies.

    Silvia Giorgi, Giovanna Leonardi, Monica Maccaferri, Elena Sbadili, Carlo Caterina, Giovanni Fera, Ambra Paolini, Leonardo Potenza, Anna Candoni, Mario Luppi, Roberto Marasca
    e2025061
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.061
    1297
    PDF: 583
    Html: 230
  • STUDY OF SERUM HAPTOGLOBIN LEVEL AND ITS RELATION TO ERYTHROPOIETIC ACTIVITY IN BETA THALASSEMIA CHILDREN .

    Seham Ragab, Manal A. Safan, Eman A. Badr
    e2015019
    2015-02-12
    https://doi.org/10.4084/mjhid.2015.019
    2252
    PDF: 1187
    HTML: 2600
    Study of serum haptoglobin level in thalassemia: 369
    Figures: 196
  • CLINICAL SIGNIFICANCE OF ASSESSMENT OF THROMBOSPONDIN AND PLACENTA GROWTH FACTOR LEVELS IN PATIENTS WITH SICKLE CELL ANEMIA: TWO CENTERS EGYPTIAN STUDIES

    adel abd elhaleim hagag, Ghada Elmashad, Aml Ezzat Abd El-Lateef
    e2014044
    2014-06-29
    https://doi.org/10.4084/mjhid.2014.044
    1855
    PDF: 943
    HTML: 2272
  • Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA

    Michele Puppi, Ilaria Sacchetti, Katia Mancuso, Paola Tacchetti, Lucia Pantani, ilaria Rizzello, Miriam Iezza, Marco Talarico, Enrica Manzato, Simone Masci, Roberta Restuccia, Simona Barbato, Silvia Armuzzi, Barbara Taurisano, Ilaria Vigliotta, Elena Zamagni
    e2025045
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.045
    1724
    PDF: 1279
    HTML: 413
  • EVOLVING DISEASE SPECTRUM AND CHARACTERISTICS OF PEOPLE WITH HIV IN EASTERN CHINA: A 12-YEAR STUDY

    Ye Xiong, Bohao Dai, Dairong Xiang, Jean-Pierre Routy, Biao Zhu
    e2025077
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.077
    547
    PDF: 242
    Html: 56
  • Antibody response to breakthrough SARS-CoV-2 infection in “booster” vaccinated patients with multiple myeloma according to B/T/NK lymphocyte absolute counts and anti-CD38 treatments

    NICOLA SGHERZA, Anna Mestice, Angela Maria Vittoria Larocca, Pellegrino Musto
    e2024022
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.022
    787
    PDF: 1171
    HTML: 89
  • NG2 MOLECULE EXPRESSION IN ACUTE LYMPHOBLASTIC LEUKEMIA B CELLS: A FLOW-CYTOMETRIC MARKER FOR THE RAPID IDENTIFICATION OF KMT2A GENE REARRANGEMENTS

    Maria Laura Bisegna, Nadia Peragine, Loredana Elia, Mabel Matarazzo, Maria Laura Milani, Stefania Intoppa, Mariangela Di Trani, Francesco Malfona, Maurizio Martelli, Maria Stefania De Propris
    e2024018
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.018
    1012
    PDF: 1313
    Suppl. Files: 836
    HTML: 181
  • The MINI-POLATUZUMAB VEDOTINE PLUS CHP (POLA-R-CHP) VS. MINI-R-CHOP IN PATIENTS OVER 80 YEARS OF AGE WITH DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE, PROPENSITY SCORE-MATCHED ANALYSIS STRATIFIED BY SIMPLIFIED FRAILTY SCORE PolaRCHP vs. RCHOP for older patients

    Shuku Sato
    e2025070
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.070
    1378
    PDF: 446
    HTML: 113
  • COMPARISON OF THE POWER OF PROCALCITONIN AND C-REACTIVE PROTEIN TO DISCRIMINATE BETWEEN DIFFERENT AETIOLOGIES OF FEVER IN PROLONGED PROFOUND NEUTROPENIA: A SINGLE-CENTRE PROSPECTIVE OBSERVATIONAL STUDY.

    Anke Verlinden, Veronique De Vroey, Herman Goossens, Ella Roelant, Ann Van de Velde, Zwi Berneman, Wilfried Schroyens, Alain Gadisseur
    e2019023
    2019-02-26
    https://doi.org/10.4084/mjhid.2019.023
    6805
    PDF: 1107
    HTML: 470
  • Parasitic hypereosinophilia in childhood: a diagnostic challenge

    Roberto Antonucci, Nadia Vacca, Giulia Boz, Cristian Locci, Rosanna Mannazzu, Claudio Cherchi, Giacomo Lai, Claudio Fozza
    e2018034
    2018-05-01
    https://doi.org/10.4084/mjhid.2018.034
    2626
    PDF: 828
    HTML: 332
    Figure 1: 177
  • THERAPEUTIC GENE EDITING FOR HEMOGLOBINOPATHIES Gene therapy for Hemoglobinopathies.

    Ugo Testa, Giuseppe Leone, Prof. M.D. Cappellini
    e2024068
    2024-08-31
    https://doi.org/10.4084/MJHID.2024.068
    2239
    PDF: 1343
    Html: 315
  • Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multirefractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists

    Monica Carpenedo, Dr, Dr, Dr
    e2023021
    2023-02-28
    https://doi.org/10.4084/MJHID.2023.021
    1233
    PDF: 1132
    HTML: 712
  • PREVALENCE OF ß-THALASSEMIA MUTATIONS AMONG NORTHEASTERN IRANIAN POPULATION AND THEIR IMPACTS ON HEMATOLOGICAL INDICES AND APPLICATION OF PRENATAL DIAGNOSIS, A SEVEN-YEARS STUDY

    Mohammad Ehsan Jaripour, Kourosh Hayatigolkhatmi, Vahid Iranmanesh, Farhad Khadivi Zand, Zahra Badiei, Hamid Farhangi, Ali Ghasemi, Abdollah Banihashem, Reza Jafarzadeh Esfehani, Ariane Sadr-Nabavi
    e2018042
    2018-07-01
    https://doi.org/10.4084/mjhid.2018.042
    2455
    PDF: 985
    HTML: 401
    Supplementary table 1: 232
    Some of the mutation detection samples: 227
  • HEMATOLOGICAL ABNORMALITIES BEYOND LYMPHOCYTOSIS DURING INFECTIOUS MONONUCLEOSIS: EPSTEIN-BARR VIRUS-INDUCED THROMBOCYTOPENIA THROMBOCYTOPENIA DURING INFECTIOUS MONONUCLEOSIS

    Arturo Gonzalez Quintela, Emilio Paez-Guillan, Joaquin Campos-Franco, Rosario Alende
    e2023023
    2023-02-28
    https://doi.org/10.4084/MJHID.2023.023
    2203
    HTML: 585
    PDF: 1365
  • HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ

    Anna Maria Testi, Mazin Faisal Al-Jadiry, Maria Luisa Moleti, Stefania Uccini, Amir Fadhil Al-Darraij, Raghad Majid Al-Saeed, Hasanein Habeeb Ghali, Ahmed Hatem Sabhan, Samaher Abdulrazzaq Fadhil, Safaa Abdulelah Al-Badri, Adil Rabeea Alsaadawi, Ameer Dh Hameedi, Manhal Hashim Shanshal, Yasir Saadoon Al-Agele, Fatimah Abdul Ridha Al-Saffar, Nihal Khalid Yaseen, Alfonso Piciocchi, Giovanni Marsili, Salma Abbas Al-Hadad
    e2024053
    2024-06-29
    https://doi.org/10.4084/MJHID.2024.053
    1064
    PDF: 948
    Suppl. Files: 606
    HTML: 97
  • Extending Long Term Follow-up of Patient With Acute Myeloid Leukemia after Autologous Stem Cell Transplantation: disclosing late mortality and causes of death.

    Federica Sorà, Patrizia Chiusolo, luca laurenti, idanna innocenti, francesco autore, andrea corbingi, andrea corbingi, sabrina giammarco, elisabetta metafuni, andrea bacigalupo, simona sica
    e2020030
    2020-04-27
    https://doi.org/10.4084/mjhid.2020.030
    1455
    PDF: 634
    HTML: 214
  • Lenalidomide and temozolomide combination in a very elderly patient with CNS relapse of diffuse large b-cell lymphoma.

    Emanuele Cencini, Alberto Fabbri, Umberto Arrigucci, Alfonso Cerase, Monica Bocchia
    e2017040
    2017-06-16
    https://doi.org/10.4084/mjhid.2017.040
    3507
    PDF: 1067
    HTML: 1020
    Figure 1: 192
  • LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE

    Massimo Breccia, Corrado Girmenia, Roberto Latagliata, Giuseppina Loglisci, Michelina Santopietro, Vincenzo Federico, Luigi Petrucci, Alessandra Serrao, Adriano Salaroli, Giuliana Alimena
    e2011021
    2011-05-16
    https://doi.org/10.4084/mjhid.2011.021
    1666
    PDF: 811
    HTML: 871
    jdoe, table 2 infections CML .doc: 206
    jdoe, table 1 infections CML .doc: 195
  • THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association

    Katia Paciaroni, Selenia Campagna, Nicoletta Villiva', Enrico Maffini, Francesca Celesti, Attilio Tordi, Mariangela Lombardi, Giulia Dragonetti, Tommaso Caravita di Toritto
    e2025023
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.023
    1109
    PDF: 1221
    HTML: 104
  • COMPARISON OF PRESEPSIN, PROCALCITONIN, INTERLEUKIN-8 AND C-REACTIVE PROTEIN IN PREDICTING BACTERAEMIA IN FEBRILE NEUTROPENIC ADULT PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES

    Irena Kostic, Carmela Gurrieri, Elisa Piva, Gianpietro Semenzato, Mario Plebani, Ilaria Caputo, Fabrizio Vianello
    e2019047
    2019-08-29
    https://doi.org/10.4084/mjhid.2019.047
    2099
    PDF: 1299
    HTML: 386
  • Kikuchi-Fujimoto Disease in the United States: Three Case Reports and Review of the Literature

    Darcie M Deaver, Mojdeh Naghashpour, Lubomir Sokol
    e2014001
    2013-12-31
    https://doi.org/10.4084/mjhid.2014.001
    1794
    PDF: 856
    HTML: 3719
  • CLINICAL IMPACT OF ELTROMBOPAG-ASSOCIATED IRON CHELATION IN ADULTS WITH IMMUNE THROMBOCYTOPENIA: A MULTICENTER REAL-WORLD STUDY

    Ahmet Yigitbasi, Elif Gulsum Umit, Ufuk Demirci, Guray Aygun, Nese Varli, Elif Aksoy, Fehmi Hindilerden, Emine Gulturk, Eren Arslan Davulcu, Ahmet Muzaffer Demir
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.027
    829
    PDF: 753
    HTML: 150
  • THALIDOMIDE FOR PATIENTS WITH THALASSEMIA INTERMEDIA: A RETROSPECTIVE MULTICENTER CLINICAL STUDY

    Kun Yang, Yi Wu, Yali Zhou, Tianhong Zhou, Li Wang, Zhili Geng, Xiaolin Yin
    e2020021
    2020-04-27
    https://doi.org/10.4084/mjhid.2020.021
    2278
    PDF: 1272
    HTML: 375
  • Skin Involvement in Primary Systemic Amyloidosis

    susheel kumar
    e2013005
    2013-01-02
    https://doi.org/10.4084/mjhid.2013.005
    1687
    PDF: 911
    HTML: 4400
    Figure 1. Photographs showing (a) enlarged tongue with (b) teeth marks over the lateral margin and (c, d) multiple, papular lesions over lower chest wall: 192
    Figure 2. Microphotograph showing pink eosinophilic homogenous material in the dermis, H&E X 20: 171
    Figure 3. Pink eosinophilic material showing pale orange positivity with Congo red stain: 194
  • NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES

    Francesco D'Alò, Mariangela Greco, Marianna Criscuolo, Maria Teresa Voso
    e2010021
    2010-08-11
    https://doi.org/10.4084/mjhid.2010.021
    2022
    PDF: 1039
    HTML: 736
  • MOLECULAR CHARACTERIZATION OF EPSTEIN - BARR VIRUS BASED ON EBNA3C PROTEIN AMONG HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS IN JORDAN

    Rabaa Athamneh, Hiba Swaity, Waleed Almomani, Hayyan. Taweil , Assia Benbraiek, Anas Khalifeh
    e2025032
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.032
    875
    PDF: 889
    HTML: 130
  • Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)

    Eugenio Galli, Silvia Bellesi, Marcello Viscovo, Federica Sorà, Stefan Hohaus, Nicola Piccirillo, Luca Laurenti, Patrizia Chiusolo, Valerio De Stefano, Simona Sica, Gina Zini
    e2021066
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.066
    1598
    PDF: 561
    HTML: 238
  • GENETIC HETEROGENEITY OF BETA GLOBIN MUTATIONS AMONG ASIAN-INDIANS AND IMPORTANCE IN GENETIC COUNSELLING AND DIAGNOSIS

    Ravindra Kumar, Kritanjali Singh, Inusha Panigrahi, Sarita Agarwal
    e2013003
    2013-01-01
    https://doi.org/10.4084/mjhid.2013.003
    1805
    PDF: 1309
    HTML: 11540
    Figure1: 184
    Figure 2: 188
  • EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN CHILDREN: THE EXPERIENCE IN CHINA

    Li Zhang, Xiaofan Zhu
    e2012012
    2012-03-10
    https://doi.org/10.4084/mjhid.2012.012
    2420
    PDF: 866
    HTML: 2178
    New table Chinese children with APL: 172
  • ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY

    Eldad J Dann
    e2014063
    2014-09-05
    https://doi.org/10.4084/mjhid.2014.063
    2165
    PDF: 1338
    HTML: 3508
  • Addition of daratumumab to first-line therapy of newly diagnosed multiple myeloma in patients eligible for autologous stem cell transplantation: a single-center real-life experience

    Edoardo Olivari
    e2025040
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.040
    1085
    PDF: 790
    HTML: 191
  • CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment

    Ugo Testa, Elvira Pelosi, Dr. Germana Castelli
    e2024077
    2024-10-31
    https://doi.org/10.4084/MJHID.2024.077
    1786
    PDF: 874
    HTML: 630
  • THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone

    George J Kontoghiorghes, Marios Kleanthous, Christina N. Kontoghiorghe
    e2020011
    2020-01-01
    https://doi.org/10.4084/mjhid.2020.011
    2471
    PDF: 1614
    HTML: 664
  • Low incidence of anti-pf4/heparin antibodies in patients with acute myelogenous leukemia.

    Håkon Reikvam, Ingvild Jenssen Lægreid, Ingvild Hausberg Sørvoll, Tom Sollid, Trude Victoria Mørtberg, Maria Therese Ahlén, Silje Johansen
    e2024057
    2024-06-29
    https://doi.org/10.4084/MJHID.2024.057
    965
    PDF: 891
    HTML: 168
  • Simultaneous dual pathology in lymph node

    Prakas Kumar Mandal, Supriyo Sarkar, Malay Kumar Ghosh, Maitreyee Bhattacharyya
    e2014036
    2014-05-31
    https://doi.org/10.4084/mjhid.2014.036
    1683
    PDF: 715
    HTML: 7769
    Simultaneous dual pathology in lymph node: 182
    Simultaneous dual pathology in lymph node: 181
    Simultaneous dual pathology in lymph node: 157
    Simultaneous dual pathology in lymph node: 195
    Simultaneous dual pathology in lymph node: 184
  • COMMENT TO THE ARTICLE PREVENTION OF ? THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS. BY KOREN ET AL.

    Antonio Amato
    e2014021
    2014-03-10
    https://doi.org/10.4084/mjhid.2014.021
    1360
    PDF: 824
    HTML: 2410
  • CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES

    Ugo Testa, Prof. Patrizia Chiusolo, Dr. Elvira Pelosi, Dr. Germana Castelli, Giuseppe Leone
    e2024031
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.031
    2243
    PDF: 2076
    HTML: 203
  • Idiopathic pulmonary embolism in a case of severe family ANKRD26 thrombocytopenia

    Jérôme Guison, Gilles Blaison, Oana Stoica, Remy Hurstel, Marie Favier, Remi Favier
    e2017038
    2017-06-16
    https://doi.org/10.4084/mjhid.2017.038
    2251
    PDF: 851
    HTML: 946
    Patient’s family tree: 187
  • MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA

    Melanie Joannides, Ashley N Mays, Anita R Mistry, Syed Khizer Hasan, Andreas Reiter, Joseph L Wiemels, Carolyn A Felix, Francesco Lo-Coco, Neil Osheroff, Ellen Solomon, David Grimwade
    e2011045
    2011-10-24
    https://doi.org/10.4084/mjhid.2011.045
    2926
    PDF: 874
    HTML: 6560
    Untitled: 252
    Untitled: 204
    Untitled: 226
    Untitled: 232
  • Nodular lymphocyte-predominant Hodgkin lymphoma in a patient with Familial Mediterranean Fever

    Marina Belia, Asimina Papanikolaou, Panagiotis Skendros, Theodoros Vassilakopoulos
    e2022059
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.059
    1001
    PDF: 523
    HTML: 304
401 - 450 of 457 items << < 4 5 6 7 8 9 10 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.